Inventor
MEINHARD HASSLACHER
Inventor
AT
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes25%
A61KPreparations for medical, dental or toiletry purposes16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
C07KPeptides13%
B01DSeparation9%
C12MApparatus for enzymology or microbiology9%
C12YEnzymes9%
A61LMethods or apparatus for sterilising materials or objects in general3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
PatentTitleYear
12,492,390Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof202512,257,277Adeno-associated virus formulations202512,246,047Adeno-associated virus purification methods202512,071,468Purification of Factor VIII subspecies202411,981,934Adeno-associated virus purification methods202411,661,593Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof202311,583,563Adeno-associated virus formulations202311,421,202Virus filtration of cell culture media202211,299,533Purification of factor VIII subspecies202211,254,921ADAMTS13 protein cell culture supernatant2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to TAKEDA PHARMACEUTICALS CO (10)· patent assignee history
2022–2025Based in AT· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TAKEDA PHARMACEUTICALS CO | 10 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| AT | 10 | 2022–2025 |